Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder.
Häkkinen K, Kiiski JI, Lähteenvuo M, Jukuri T, Suokas K, Niemi-Pynttäri J, Kieseppä T, Männynsalo T, Wegelius A, Haaki W, Lahdensuo K, Kajanne R, Kaunisto MA, Tuulio-Henriksson A, Kampman O, Hietala J, Veijola J, Lönnqvist J, Isometsä E, Paunio T, Suvisaari J, Kalso E, Niemi M, Tiihonen J, Daly M, Palotie A, Ahola-Olli AV. Häkkinen K, et al. Among authors: kiiski ji. Pharmacogenomics J. 2022 May;22(3):166-172. doi: 10.1038/s41397-022-00270-y. Epub 2022 Feb 23. Pharmacogenomics J. 2022. PMID: 35197553 Free PMC article.
NTHL1 is a recessive cancer susceptibility gene.
Nurmi AK, Pelttari LM, Kiiski JI, Khan S, Nurmikolu M, Suvanto M, Aho N, Tasmuth T, Kalso E, Schleutker J, Kallioniemi A, Heikkilä P; FinnGen; Aittomäki K, Blomqvist C, Nevanlinna H. Nurmi AK, et al. Among authors: kiiski ji. Sci Rep. 2023 Nov 30;13(1):21127. doi: 10.1038/s41598-023-47441-w. Sci Rep. 2023. PMID: 38036545 Free PMC article.
Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.
Kiiski JI, Neuvonen M, Kurkela M, Hirvensalo P, Hämäläinen K, Tarkiainen EK, Sistonen J, Korhonen M, Khan S, Orpana A, Filppula AM, Lehtonen M, Niemi M. Kiiski JI, et al. Hum Genomics. 2024 Feb 1;18(1):11. doi: 10.1186/s40246-024-00579-8. Hum Genomics. 2024. PMID: 38303026 Free PMC article.
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.
Nurmi A, Muranen TA, Pelttari LM, Kiiski JI, Heikkinen T, Lehto S, Kallioniemi A, Schleutker J, Bützow R, Blomqvist C, Aittomäki K, Nevanlinna H. Nurmi A, et al. Among authors: kiiski ji. Int J Cancer. 2019 Nov 15;145(10):2692-2700. doi: 10.1002/ijc.32309. Epub 2019 Apr 25. Int J Cancer. 2019. PMID: 30927251 Free PMC article.
Screening of HELQ in breast and ovarian cancer families.
Pelttari LM, Kinnunen L, Kiiski JI, Khan S, Blomqvist C, Aittomäki K, Nevanlinna H. Pelttari LM, et al. Among authors: kiiski ji. Fam Cancer. 2016 Jan;15(1):19-23. doi: 10.1007/s10689-015-9838-4. Fam Cancer. 2016. PMID: 26351136
30 results